Device Trial Radar · NCT05984186
Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline
Last checked: Nov 20, 2026Latest source record: Oct 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Mar 6, 2023
Primary completion
Jul 31, 2023
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Vapotherm, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Auburn University
- First posted
- Aug 9, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 30 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study will evaluate the impact of high velocity therapy (HVT) on reduction of work of breathing (as implied by breath frequency) and enhanced blood lactate decline during recovery from a Wingate-type Exercise test. The study will include four study segments, corresponding to four different therapy settings.
Conditions
- Dyspnea
- Lactic Acidosis
- Muscle
- Breathlessness
- Exercise
- Recovery
Interventions
High Velocity TherapyDevice
FiO2=100% with Flow=5LPM FiO2=21% with Flow=25-35LPM FiO2=100% with Flow=25-35LPM FiO2=21% with Flow=5LPM
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blood Lactate ChangeTime frame: At rest (TR) and during recovery from the Wingate test at minute 2 (T2) minute 4 (T4), minute 6 (T6), minute 8 (T8), minute 10 (T10) minute 15 (T15), minute 20 (T20), minute 25 (T25), minute 30 (T30) minute 40 (T40), minute 50 (T50) minute 60 (T60).
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Auburn University
Auburn, Alabama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.